85.76
전일 마감가:
$84.93
열려 있는:
$83.75
하루 거래량:
1.20M
Relative Volume:
0.90
시가총액:
$9.59B
수익:
$2.86B
순이익/손실:
$239.88M
주가수익비율:
41.03
EPS:
2.0903
순현금흐름:
$506.94M
1주 성능:
+1.18%
1개월 성능:
-14.16%
6개월 성능:
-1.11%
1년 성능:
-21.98%
퍼킨엘머 Stock (RVTY) Company Profile
명칭
Revvity Inc
전화
781-663-6900
주소
77 4TH AVENUE, WALTHAM
Compare RVTY vs TMO, DHR, IDXX, A, WAT
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
RVTY
Revvity Inc
|
85.76 | 9.50B | 2.86B | 239.88M | 506.94M | 2.0903 |
|
TMO
Thermo Fisher Scientific Inc
|
470.21 | 172.63B | 44.56B | 6.72B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
190.11 | 135.42B | 24.57B | 3.60B | 5.26B | 5.051 |
|
IDXX
Idexx Laboratories Inc
|
579.85 | 45.95B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
111.75 | 31.51B | 7.07B | 1.29B | 993.00M | 4.5355 |
|
WAT
Waters Corp
|
299.57 | 28.94B | 3.17B | 642.63M | 516.49M | 10.77 |
퍼킨엘머 Stock (RVTY) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-15 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2025-12-09 | 개시 | Goldman | Neutral |
| 2025-10-16 | 개시 | Guggenheim | Neutral |
| 2025-05-01 | 업그레이드 | UBS | Neutral → Buy |
| 2025-01-10 | 다운그레이드 | Bernstein | Outperform → Mkt Perform |
| 2024-12-13 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2024-10-15 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2024-08-28 | 개시 | Wells Fargo | Equal Weight |
| 2024-07-08 | 개시 | Leerink Partners | Outperform |
| 2024-06-03 | 재개 | Jefferies | Hold |
| 2024-01-16 | 다운그레이드 | UBS | Buy → Neutral |
| 2024-01-04 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2023-12-19 | 개시 | Wells Fargo | Equal Weight |
| 2023-12-13 | 개시 | Wolfe Research | Peer Perform |
| 2023-09-28 | 개시 | Bernstein | Outperform |
| 2023-07-19 | 개시 | Raymond James | Outperform |
| 2023-05-23 | 재개 | Goldman | Buy |
모두보기
퍼킨엘머 주식(RVTY)의 최신 뉴스
Revvity blends creativity and robotics at Shanghai site for New Year festivities - Traders Union
Emerald Growth Equity Strategy sold Revvity (RVTY) in Q4 - MSN
Revvity Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Revvity targets 2%-4% organic growth for 2025 as China diagnostics faces new policy headwinds - MSN
Revvity (RVTY) awards stock options and RSUs to officer Anita Gonzales - Stock Titan
Research Tools & Consumables Stocks Q4 Results: Benchmarking Revvity (NYSE:RVTY) - Yahoo Finance
Here's why you should retain Revvity stock in your portfolio for now - MSN
Revvity Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Tranche Update on Revvity, Inc.'s Equity Buyback Plan announced on October 27, 2025. - marketscreener.com
REVVITY, INC. ($RVTY) CEO 2025 Pay Revealed - Quiver Quantitative
Revvity Inc. stock underperforms Monday when compared to competitors despite daily gains - MarketWatch
John Chevedden Submits Shareholder Proposal to Revvity - marketscreener.com
Revvity Receives Shareholder Proposal from John Chevedden - marketscreener.com
Emerald Growth Equity Strategy Sold Revvity (RVTY) in Q4 - Insider Monkey
[ARS] REVVITY, INC. SEC Filing - Stock Titan
Revvity (RVTY) 2026 proxy outlines virtual meeting, 10 directors and governance votes - Stock Titan
Revvity Inc. (NYSE:RVTY) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat
EdgePoint Investment Group Inc. Acquires 1,784,620 Shares of Revvity Inc. $RVTY - MarketBeat
Revvity Inc. Stock (ISIN: US76155R1086) Faces Headwinds in Diagnostics Amid Life Sciences Recovery - AD HOC NEWS
Analysts Have Conflicting Sentiments on These Healthcare Companies: Revvity (RVTY) and Candel Therapeutics (CADL) - The Globe and Mail
Stifel reiterates Hold on Revvity stock, keeps $110 price target By Investing.com - Investing.com India
Stifel reiterates Hold on Revvity stock, keeps $110 price target - Investing.com
Korea Investment CORP Sells 29,300 Shares of Revvity Inc. $RVTY - MarketBeat
Revvity Inc. $RVTY Shares Sold by Capital Research Global Investors - MarketBeat
Revvity Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Barclays PLC Sells 37,149 Shares of Revvity Inc. $RVTY - MarketBeat
Revvity at Conference Barclays: Strategic Insights for Growth By Investing.com - Investing.com India
Revvity at Conference Barclays: Strategic Insights for Growth - Investing.com
Revvity Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Revvity (RVTY) awards officer Anita Gonzales stock options and RSUs - Stock Titan
Understanding Momentum Shifts in (RVTY) - Stock Traders Daily
Dimensional Fund Advisors LP Purchases 596,436 Shares of Revvity Inc. $RVTY - MarketBeat
How The Revvity (RVTY) Narrative Is Shifting With Higher Targets And Tempered Growth Assumptions - Yahoo Finance
Bretton Fund exits UNP and RVTY - MSN
Revvity, Inc. Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
Revvity declares $0.07 dividend - MSN
Neuberger Berman Group LLC Buys 450,648 Shares of Revvity Inc. $RVTY - MarketBeat
Trend Report: Whats the MACD signal for Revvity Inc2025 Market Overview & Comprehensive Market Scan Reports - baoquankhu1.vn
Trading Recap: Is Revvity Inc a play on infrastructure spending2025 Volatility Report & Consistent Growth Equity Picks - baoquankhu1.vn
Tenet Healthcare, Revvity, Avantor, Azenta, and Elanco Shares Plummet, What You Need To Know - Yahoo Finance
Why is Revvity (RVTY) down 5.1% since last earnings report? - MSN
Revvity (NYSE: RVTY) virtual annual meeting Apr 28 — key governance votes - Stock Titan
Revvity Inc (RVTY) Stock Price Down 4.85% on Mar 6 - GuruFocus
Bretton Fund Exited Revvity (RVTY) in 2025 - Insider Monkey
Revvity Inc. stock outperforms competitors on strong trading day - MarketWatch
Why Is Revvity (RVTY) Down 5.1% Since Last Earnings Report? - Yahoo Finance
Here's Why You Should Retain Revvity Stock in Your Portfolio for Now - Finviz
RVTY Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Revvity at TD Cowen: Strategic Growth and Margin Expansion - Investing.com
Revvity at TD Cowen: Strategic Growth and Margin Expansion By Investing.com - Investing.com South Africa
Here's Why Keeping Revvity Stock in Your Portfolio Makes Sense at This Time - Bitget
퍼킨엘머 (RVTY) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):